OV-MZ-32 (Q54936859)

From Wikidata

Jump to navigation Jump to search

cell line

OVMZ32

Language	Label	Description	Also known as
English	OV-MZ-32	cell line	OVMZ32

Statements

1 reference

Cellosaurus release 44

27 January 2023

cancer cell line

1 reference

Cellosaurus release 44

27 January 2023

described by source

Growth suppression of human ovarian carcinoma OV-MZ-2a and OV-MZ-32 cells mediated by gene transfer of wild-type p53 enhanced by chemotherapy in vitro.

1 reference

Cellosaurus release 44

27 January 2023

Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3.

1 reference

Cellosaurus release 44

27 January 2023

Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status

1 reference

Cellosaurus release 44

27 January 2023

established from medical condition

ovarian carcinoma

1 reference

Cellosaurus release 44

27 January 2023

derived from organism type

1 reference

Cellosaurus release 44

27 January 2023

Identifiers

1 reference

Cellosaurus release 44

27 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54936859&oldid=1861683336"